PAM
MDCO

Premier Asset Management’s Medicines Co MDCO Stock Holding History

Premier Asset Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-25,248
Closed -$483K – 151
2018
Q4 		$483K Buy
+25,248
New +$587K 0.13% 97

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
BM
Bridger Management New York $150M AUM 17.71% 1-Year Est. Return

Premier Asset Management's MDCO Position: Q1 2019 in Review

Premier Asset Management sold out of Medicines Co (MDCO) in Q1 2019, closing a stake of 25,248 shares — an estimated $483K sold.

Premier Asset Management first reported a position in MDCO in Q4 2018 and held it in 1 quarter. The position peaked at $483K in Q4 2018. 203 funds tracked by Wall St. Rank hold MDCO as of Q1 2019.

  • Premier Asset Management reported no remaining Medicines Co position as of Q1 2019 after selling out during the quarter.
  • Premier Asset Management sold 25,248 Medicines Co shares in Q1 2019, an estimated $483K.
  • Premier Asset Management first reported a position in Medicines Co in Q4 2018 and held it in 1 quarter.
  • Premier Asset Management's Medicines Co position peaked at $483K in Q4 2018.
  • 203 funds tracked by Wall St. Rank held Medicines Co as of Q1 2019.

Based on Premier Asset Management's 13F filing for Q1 2019, filed 15 May 2019.